Trial Profile
Single Site, Phase II, Double Blind, Randomized, Placebo Controlled Study of the Effect of Dutasteride (Avodart) 0.5mg on the Volume and Characteristics of Prostate Cancer, as Assessed by Multifunctional Magnetic Resonance Imaging (MRI) With Lower Risk Prostate Cancer Suitable for Active Surveillance. (MAPPED TRIAL)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms MAPPED
- 01 Jul 2019 Status changed from active, no longer recruiting to completed.
- 01 Jan 2013 Study design published in Contemporary Clinical Trials.
- 03 Feb 2012 United Kingdom Clinical Research Network reports accrual date changed from 102% to 133%.